New role for Hippo pathway in suppressing cancer immunity

Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.